Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Stanford, California Clinical Trials

A listing of Stanford, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (8) clinical trials

A Pilot Study of 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

Primary Objective: To evaluate 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for biopsy guidance in patients with suspected prostate cancer. Exploratory Objective: Correlation of 68Ga PSMA 11 uptake and Gleason score at biopsy Correlation of 68Ga RM2 and Gleason score at biopsy

Phase

0.31 miles

Learn More »

The Objective of This Study is to Compare the Efficacy and Safety of Beremagene Geperpavec (B-VEC) Topical Gel With That of Placebo for the Treatment of Dystrophic Epidermolysis Bullosa (DEB).

Thirty (30) participants with DEB, aged 6 months or older at time of consent are planned for this Phase III study. The trial duration for each subject is about 6 months, with administration occurring once weekly. A Safety Follow-up Visit occurring 30 days from the date of final treatment with …

Phase

0.74 miles

Learn More »

Gene Transfer Study in Patients With Late Onset Pompe Disease

This study (FORTIS) will evaluate the safety and efficacy of an investigational gene replacement therapy, AT845, in adult subjects with LOPD. Subjects will receive a single dose of AT845 delivered via intravenous (IV) infusion. Up to 2 nominal dose levels of AT845 are planned to be evaluated in FORTIS. A …

Phase

3.06 miles

Learn More »

Re-Energize Fontan

Survival of children with single ventricles ("half a heart") beyond the neonatal period has increased dramatically with the staged Fontan palliation. Yet, long-term morbidity remains high. By the age of 40, 50% of Fontan patients will have died or undergone heart transplantation. With >1,000 Fontan palliations performed in the US …

Phase N/A

3.06 miles

Learn More »

Performance Evaluation of the VIDAS TB-IGRA Assay.

Tuberculosis (TB) infection is one of the top 10 causes of death in the world and the leading cause of death due to a single infectious agent. Millions of people are infected with TB each year which can pose significant economic and health care burdens on the global population. TB …

Phase N/A

3.06 miles

Learn More »

A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

Patients will be randomized in a 1:1 ratio to the following monthly treatment groups: Zimura 2 mg Sham At month 12, the patients in the Zimura 2mg treatment group will be re-randomized to receive the study drug either on a monthly basis or on an every other month basis The …

Phase

5.38 miles

Learn More »

Assessing Patient-Reported Experience of Care for Home Dialysis (ASPIRED)

Assessment of patient experience and satisfaction with care among individuals undergoing maintenance dialysis in the United States is a national health care priority and mandated by Congress. No validated instruments are available to measure the patient-reported experience of care in-home dialysis patients. Such tools are needed as more patients are …

Phase N/A

5.38 miles

Learn More »

Virtual Patient Behavioral Response Training for Family Caregivers

The goal of this study is to develop and evaluate the Caring Response mobile app, containing a training that builds skills and stimulates practice. The investigators are evaluating different materials, which may encourage caregiver participation, enable user interaction, and promote better assimilation of concepts. The research team is designing the …

Phase

6.25 miles

Learn More »